Global Hydroxycarbamide Market Research Report 2020

Publisher Name :
Date: 03-Jan-2020
No. of pages: 122
Inquire Before Buying

Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.

Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.

The classification of Hydroxycarbamide includes capsule and tablet, and the proportion of capsule in 2016 is about 63%, and the proportion is in decreasing trend from 2012 to 2016.

Hydroxycarbamide is widely used for sickle cell disease, cancer and other disease. The most proportion of Hydroxycarbamide is used for sickle cell disease, and the proportion in 2016 is 45%.

Asia Pacific is the largest supplier of Hydroxycarbamide, with a production market share nearly 59% in 2016.

Middle East and Africa is the largest consumption place, with a consumption market share nearly 36% in 2016. Following Middle East and Africa, Asia Pacific is the second largest consumption place with the consumption market share of 20%.

Market competition is not intense. Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech, Par Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Hydroxycarbamide market is valued at 210.5 million US$ in 2020 is expected to reach 309.5 million US$ by the end of 2026, growing at a CAGR of 5.6% during 2021-2026.

This report focuses on Hydroxycarbamide volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hydroxycarbamide market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Hydroxycarbamide market is segmented into

- Capsule

- Tablet

Segment by Application

- Sickle Cell Disease

- Cancer

- Other

Global Hydroxycarbamide Market: Regional Analysis

The Hydroxycarbamide market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Hydroxycarbamide market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Hydroxycarbamide Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Hydroxycarbamide market include:

- Bristol Myers Squibb

- Taj Pharma

- Beijing Jialin Pharma

- Qilu Pharmaceutical

- Teva Pharma

- Cipla

- Zydus Cadila

- United Biotech

- Par Pharma

- Khandelwal Laboratories

- Alkem (Cytomed)

- Samarth Pharma

- VHB Life Sciences

Global Hydroxycarbamide Market Research Report 2020

Table of Contents
1 Hydroxycarbamide Market Overview
1.1 Product Overview and Scope of Hydroxycarbamide
1.2 Hydroxycarbamide Segment by Type
1.2.1 Global Hydroxycarbamide Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Capsule
1.2.3 Tablet
1.3 Hydroxycarbamide Segment by Application
1.3.1 Hydroxycarbamide Sales Comparison by Application: 2020 VS 2026
1.3.2 Sickle Cell Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global Hydroxycarbamide Market Size Estimates and Forecasts
1.4.1 Global Hydroxycarbamide Revenue 2015-2026
1.4.2 Global Hydroxycarbamide Sales 2015-2026
1.4.3 Hydroxycarbamide Market Size by Region: 2020 Versus 2026
2 Global Hydroxycarbamide Market Competition by Manufacturers
2.1 Global Hydroxycarbamide Sales Market Share by Manufacturers (2015-2020)
2.2 Global Hydroxycarbamide Revenue Share by Manufacturers (2015-2020)
2.3 Global Hydroxycarbamide Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Hydroxycarbamide Manufacturing Sites, Area Served, Product Type
2.5 Hydroxycarbamide Market Competitive Situation and Trends
2.5.1 Hydroxycarbamide Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Hydroxycarbamide Players (Opinion Leaders)
3 Hydroxycarbamide Retrospective Market Scenario by Region
3.1 Global Hydroxycarbamide Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Hydroxycarbamide Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Hydroxycarbamide Market Facts & Figures by Country
3.3.1 North America Hydroxycarbamide Sales by Country
3.3.2 North America Hydroxycarbamide Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hydroxycarbamide Market Facts & Figures by Country
3.4.1 Europe Hydroxycarbamide Sales by Country
3.4.2 Europe Hydroxycarbamide Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hydroxycarbamide Market Facts & Figures by Region
3.5.1 Asia Pacific Hydroxycarbamide Sales by Region
3.5.2 Asia Pacific Hydroxycarbamide Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hydroxycarbamide Market Facts & Figures by Country
3.6.1 Latin America Hydroxycarbamide Sales by Country
3.6.2 Latin America Hydroxycarbamide Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Hydroxycarbamide Market Facts & Figures by Country
3.7.1 Middle East and Africa Hydroxycarbamide Sales by Country
3.7.2 Middle East and Africa Hydroxycarbamide Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Hydroxycarbamide Historic Market Analysis by Type
4.1 Global Hydroxycarbamide Sales Market Share by Type (2015-2020)
4.2 Global Hydroxycarbamide Revenue Market Share by Type (2015-2020)
4.3 Global Hydroxycarbamide Price Market Share by Type (2015-2020)
4.4 Global Hydroxycarbamide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Hydroxycarbamide Historic Market Analysis by Application
5.1 Global Hydroxycarbamide Sales Market Share by Application (2015-2020)
5.2 Global Hydroxycarbamide Revenue Market Share by Application (2015-2020)
5.3 Global Hydroxycarbamide Price by Application (2015-2020)
6 Company Profiles and Key Figures in Hydroxycarbamide Business
6.1 Bristol Myers Squibb
6.1.1 Corporation Information
6.1.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
6.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Bristol Myers Squibb Products Offered
6.1.5 Bristol Myers Squibb Recent Development
6.2 Taj Pharma
6.2.1 Taj Pharma Hydroxycarbamide Production Sites and Area Served
6.2.2 Taj Pharma Description, Business Overview and Total Revenue
6.2.3 Taj Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Taj Pharma Products Offered
6.2.5 Taj Pharma Recent Development
6.3 Beijing Jialin Pharma
6.3.1 Beijing Jialin Pharma Hydroxycarbamide Production Sites and Area Served
6.3.2 Beijing Jialin Pharma Description, Business Overview and Total Revenue
6.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Beijing Jialin Pharma Products Offered
6.3.5 Beijing Jialin Pharma Recent Development
6.4 Qilu Pharmaceutical
6.4.1 Qilu Pharmaceutical Hydroxycarbamide Production Sites and Area Served
6.4.2 Qilu Pharmaceutical Description, Business Overview and Total Revenue
6.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Qilu Pharmaceutical Products Offered
6.4.5 Qilu Pharmaceutical Recent Development
6.5 Teva Pharma
6.5.1 Teva Pharma Hydroxycarbamide Production Sites and Area Served
6.5.2 Teva Pharma Description, Business Overview and Total Revenue
6.5.3 Teva Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Teva Pharma Products Offered
6.5.5 Teva Pharma Recent Development
6.6 Cipla
6.6.1 Cipla Hydroxycarbamide Production Sites and Area Served
6.6.2 Cipla Description, Business Overview and Total Revenue
6.6.3 Cipla Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Cipla Products Offered
6.6.5 Cipla Recent Development
6.7 Zydus Cadila
6.6.1 Zydus Cadila Hydroxycarbamide Production Sites and Area Served
6.6.2 Zydus Cadila Description, Business Overview and Total Revenue
6.6.3 Zydus Cadila Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Zydus Cadila Products Offered
6.7.5 Zydus Cadila Recent Development
6.8 United Biotech
6.8.1 United Biotech Hydroxycarbamide Production Sites and Area Served
6.8.2 United Biotech Description, Business Overview and Total Revenue
6.8.3 United Biotech Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.8.4 United Biotech Products Offered
6.8.5 United Biotech Recent Development
6.9 Par Pharma
6.9.1 Par Pharma Hydroxycarbamide Production Sites and Area Served
6.9.2 Par Pharma Description, Business Overview and Total Revenue
6.9.3 Par Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Par Pharma Products Offered
6.9.5 Par Pharma Recent Development
6.10 Khandelwal Laboratories
6.10.1 Khandelwal Laboratories Hydroxycarbamide Production Sites and Area Served
6.10.2 Khandelwal Laboratories Description, Business Overview and Total Revenue
6.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Khandelwal Laboratories Products Offered
6.10.5 Khandelwal Laboratories Recent Development
6.11 Alkem (Cytomed)
6.11.1 Alkem (Cytomed) Hydroxycarbamide Production Sites and Area Served
6.11.2 Alkem (Cytomed) Hydroxycarbamide Description, Business Overview and Total Revenue
6.11.3 Alkem (Cytomed) Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Alkem (Cytomed) Products Offered
6.11.5 Alkem (Cytomed) Recent Development
6.12 Samarth Pharma
6.12.1 Samarth Pharma Hydroxycarbamide Production Sites and Area Served
6.12.2 Samarth Pharma Hydroxycarbamide Description, Business Overview and Total Revenue
6.12.3 Samarth Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Samarth Pharma Products Offered
6.12.5 Samarth Pharma Recent Development
6.13 VHB Life Sciences
6.13.1 VHB Life Sciences Hydroxycarbamide Production Sites and Area Served
6.13.2 VHB Life Sciences Hydroxycarbamide Description, Business Overview and Total Revenue
6.13.3 VHB Life Sciences Hydroxycarbamide Sales, Revenue and Gross Margin (2015-2020)
6.13.4 VHB Life Sciences Products Offered
6.13.5 VHB Life Sciences Recent Development
7 Hydroxycarbamide Manufacturing Cost Analysis
7.1 Hydroxycarbamide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hydroxycarbamide
7.4 Hydroxycarbamide Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hydroxycarbamide Distributors List
8.3 Hydroxycarbamide Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Hydroxycarbamide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hydroxycarbamide by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Hydroxycarbamide by Type (2021-2026)
10.2 Hydroxycarbamide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hydroxycarbamide by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Hydroxycarbamide by Application (2021-2026)
10.3 Hydroxycarbamide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hydroxycarbamide by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Hydroxycarbamide by Region (2021-2026)
10.4 North America Hydroxycarbamide Estimates and Projections (2021-2026)
10.5 Europe Hydroxycarbamide Estimates and Projections (2021-2026)
10.6 Asia Pacific Hydroxycarbamide Estimates and Projections (2021-2026)
10.7 Latin America Hydroxycarbamide Estimates and Projections (2021-2026)
10.8 Middle East and Africa Hydroxycarbamide Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Hydroxycarbamide Sales (M Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Hydroxycarbamide Sales (M Units) Comparison by Application: 2020 VS 2026
Table 3. Global Hydroxycarbamide Market Size by Type (M Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Hydroxycarbamide Manufacturers Covered in This Study
Table 5. Global Hydroxycarbamide Sales (M Units) by Manufacturers (2015-2020)
Table 6. Global Hydroxycarbamide Sales Share by Manufacturers (2015-2020)
Table 7. Global Hydroxycarbamide Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Hydroxycarbamide Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Hydroxycarbamide Average Price (USD/K Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Hydroxycarbamide Sales Sites and Area Served
Table 11. Manufacturers Hydroxycarbamide Product Types
Table 12. Global Hydroxycarbamide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hydroxycarbamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxycarbamide as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Hydroxycarbamide Players
Table 16. Global Hydroxycarbamide Sales (M Units) by Region (2015-2020)
Table 17. Global Hydroxycarbamide Sales Market Share by Region (2015-2020)
Table 18. Global Hydroxycarbamide Revenue (Million US$) by Region (2015-2020)
Table 19. Global Hydroxycarbamide Revenue Market Share by Region (2015-2020)
Table 20. North America Hydroxycarbamide Sales by Country (2015-2020) (M Units)
Table 21. North America Hydroxycarbamide Sales Market Share by Country (2015-2020)
Table 22. North America Hydroxycarbamide Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Hydroxycarbamide Revenue Market Share by Country (2015-2020)
Table 24. Europe Hydroxycarbamide Sales by Country (2015-2020) (M Units)
Table 25. Europe Hydroxycarbamide Sales Market Share by Country (2015-2020)
Table 26. Europe Hydroxycarbamide Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Hydroxycarbamide Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Hydroxycarbamide Sales by Region (2015-2020) (M Units)
Table 29. Asia Pacific Hydroxycarbamide Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Hydroxycarbamide Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Hydroxycarbamide Revenue Market Share by Region (2015-2020)
Table 32. Latin America Hydroxycarbamide Sales by Country (2015-2020) (M Units)
Table 33. Latin America Hydroxycarbamide Sales Market Share by Country (2015-2020)
Table 34. Latin America Hydroxycarbamide Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Hydroxycarbamide Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Hydroxycarbamide Sales by Country (2015-2020) (M Units)
Table 37. Middle East and Africa Hydroxycarbamide Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Hydroxycarbamide Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Hydroxycarbamide Revenue Market Share by Country (2015-2020)
Table 40. Global Hydroxycarbamide Sales (M Units) by Type (2015-2020)
Table 41. Global Hydroxycarbamide Sales Share by Type (2015-2020)
Table 42. Global Hydroxycarbamide Revenue (Million US$) by Type (2015-2020)
Table 43. Global Hydroxycarbamide Revenue Share by Type (2015-2020)
Table 44. Global Hydroxycarbamide Price (USD/K Unit) by Type (2015-2020)
Table 45. Global Hydroxycarbamide Sales (M Units) by Application (2015-2020)
Table 46. Global Hydroxycarbamide Sales Market Share by Application (2015-2020)
Table 47. Global Hydroxycarbamide Sales Growth Rate by Application (2015-2020)
Table 48. Bristol Myers Squibb Hydroxycarbamide Corporation Information
Table 49. Bristol Myers Squibb Description and Business Overview
Table 50. Bristol Myers Squibb Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 51. Bristol Myers Squibb Main Product
Table 52. Bristol Myers Squibb Recent Development
Table 53. Taj Pharma Hydroxycarbamide Corporation Information
Table 54. Taj Pharma Corporation Information
Table 55. Taj Pharma Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 56. Taj Pharma Main Product
Table 57. Taj Pharma Recent Development
Table 58. Beijing Jialin Pharma Hydroxycarbamide Corporation Information
Table 59. Beijing Jialin Pharma Corporation Information
Table 60. Beijing Jialin Pharma Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 61. Beijing Jialin Pharma Main Product
Table 62. Beijing Jialin Pharma Recent Development
Table 63. Qilu Pharmaceutical Hydroxycarbamide Corporation Information
Table 64. Qilu Pharmaceutical Corporation Information
Table 65. Qilu Pharmaceutical Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 66. Qilu Pharmaceutical Main Product
Table 67. Qilu Pharmaceutical Recent Development
Table 68. Teva Pharma Hydroxycarbamide Corporation Information
Table 69. Teva Pharma Corporation Information
Table 70. Teva Pharma Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 71. Teva Pharma Main Product
Table 72. Teva Pharma Recent Development
Table 73. Cipla Hydroxycarbamide Corporation Information
Table 74. Cipla Corporation Information
Table 75. Cipla Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 76. Cipla Main Product
Table 77. Cipla Recent Development
Table 78. Zydus Cadila Hydroxycarbamide Corporation Information
Table 79. Zydus Cadila Corporation Information
Table 80. Zydus Cadila Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 81. Zydus Cadila Main Product
Table 82. Zydus Cadila Recent Development
Table 83. United Biotech Hydroxycarbamide Corporation Information
Table 84. United Biotech Corporation Information
Table 85. United Biotech Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 86. United Biotech Main Product
Table 87. United Biotech Recent Development
Table 88. Par Pharma Hydroxycarbamide Corporation Information
Table 89. Par Pharma Corporation Information
Table 90. Par Pharma Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 91. Par Pharma Main Product
Table 92. Par Pharma Recent Development
Table 93. Khandelwal Laboratories Hydroxycarbamide Corporation Information
Table 94. Khandelwal Laboratories Corporation Information
Table 95. Khandelwal Laboratories Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 96. Khandelwal Laboratories Main Product
Table 97. Khandelwal Laboratories Recent Development
Table 98. Alkem (Cytomed) Hydroxycarbamide Corporation Information
Table 99. Alkem (Cytomed) Corporation Information
Table 100. Alkem (Cytomed) Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 101. Alkem (Cytomed) Main Product
Table 102. Alkem (Cytomed) Recent Development
Table 103. Samarth Pharma Hydroxycarbamide Corporation Information
Table 104. Samarth Pharma Corporation Information
Table 105. Samarth Pharma Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 106. Samarth Pharma Main Product
Table 107. Samarth Pharma Recent Development
Table 108. VHB Life Sciences Hydroxycarbamide Corporation Information
Table 109. VHB Life Sciences Corporation Information
Table 110. VHB Life Sciences Hydroxycarbamide Sales (M Units), Revenue (Million US$), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 111. VHB Life Sciences Main Product
Table 112. VHB Life Sciences Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Hydroxycarbamide Distributors List
Table 116. Hydroxycarbamide Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Hydroxycarbamide Sales (M Units) Forecast by Type (2021-2026)
Table 121. Global Hydroxycarbamide Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Hydroxycarbamide Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Hydroxycarbamide Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Hydroxycarbamide Sales (M Units) Forecast by Application (2021-2026)
Table 125. Global Hydroxycarbamide Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Hydroxycarbamide Sales (M Units) Forecast by Region (2021-2026)
Table 127. Global Hydroxycarbamide Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Hydroxycarbamide Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Hydroxycarbamide Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Hydroxycarbamide
Figure 2. Global Hydroxycarbamide Sales Market Share by Type: 2020 VS 2026
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Hydroxycarbamide Consumption Market Share by Application: 2020 VS 2026
Figure 6. Sickle Cell Disease
Figure 7. Cancer
Figure 8. Other
Figure 9. Global Hydroxycarbamide Market Size 2015-2026 (US$ Million)
Figure 10. Global Hydroxycarbamide Sales Capacity (M Units) (2015-2026)
Figure 11. Global Hydroxycarbamide Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Hydroxycarbamide Sales Share by Manufacturers in 2020
Figure 13. Global Hydroxycarbamide Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Hydroxycarbamide Revenue in 2019
Figure 15. Hydroxycarbamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Hydroxycarbamide Sales Market Share by Region (2015-2020)
Figure 17. Global Hydroxycarbamide Sales Market Share by Region in 2019
Figure 18. Global Hydroxycarbamide Revenue Market Share by Region (2015-2020)
Figure 19. Global Hydroxycarbamide Revenue Market Share by Region in 2019
Figure 20. North America Hydroxycarbamide Sales Market Share by Country in 2019
Figure 21. North America Hydroxycarbamide Revenue Market Share by Country in 2019
Figure 22. U.S. Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 23. U.S. Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 25. Canada Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Hydroxycarbamide Sales Market Share by Country in 2019
Figure 27. Europe Hydroxycarbamide Revenue Market Share by Country in 2019
Figure 28. Germany Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 29. Germany Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 31. France Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 33. U.K. Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 35. Italy Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 37. Russia Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Hydroxycarbamide Sales Market Share by Region in 2019
Figure 39. Asia Pacific Hydroxycarbamide Revenue Market Share by Region in 2019
Figure 40. China Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 41. China Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 43. Japan Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 45. South Korea Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 47. India Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 49. Australia Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 51. Taiwan Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 53. Indonesia Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 55. Thailand Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 57. Malaysia Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 59. Philippines Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 61. Vietnam Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Hydroxycarbamide Sales Market Share by Country in 2019
Figure 63. Latin America Hydroxycarbamide Revenue Market Share by Country in 2019
Figure 64. Mexico Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 65. Mexico Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 67. Brazil Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 69. Argentina Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Hydroxycarbamide Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Hydroxycarbamide Revenue Market Share by Country in 2019
Figure 72. Turkey Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 73. Turkey Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 75. Saudi Arabia Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Hydroxycarbamide Sales Growth Rate (2015-2020) (M Units)
Figure 77. U.A.E Hydroxycarbamide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Hydroxycarbamide by Type (2015-2020)
Figure 79. Sales Market Share of Hydroxycarbamide by Type in 2019
Figure 80. Revenue Share of Hydroxycarbamide by Type (2015-2020)
Figure 81. Revenue Market Share of Hydroxycarbamide by Type in 2019
Figure 82. Global Hydroxycarbamide Sales Growth by Type (2015-2020) (M Units)
Figure 83. Global Hydroxycarbamide Sales Market Share by Application (2015-2020)
Figure 84. Global Hydroxycarbamide Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Hydroxycarbamide by Application (2015-2020)
Figure 86. Global Revenue Share of Hydroxycarbamide by Application in 2020
Figure 87. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Taj Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Beijing Jialin Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Teva Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. United Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Par Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Khandelwal Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Alkem (Cytomed) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Samarth Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. VHB Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Hydroxycarbamide
Figure 102. Manufacturing Process Analysis of Hydroxycarbamide
Figure 103. Hydroxycarbamide Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Hydroxycarbamide Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 108. North America Hydroxycarbamide Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Hydroxycarbamide Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Hydroxycarbamide Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Hydroxycarbamide Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Hydroxycarbamide Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Hydroxycarbamide Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Hydroxycarbamide Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Hydroxycarbamide Sales (M Units) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Hydroxycarbamide Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed
  • Global Amifostine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 13-Jan-2020        Price: US 3480 Onwards        Pages: 106
    Summary Market Overview The global Amifostine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 56 million by 2025, from USD 52 million in 2019. The Amifostine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis......
  • Global Methotrexate Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 10-Jan-2020        Price: US 3480 Onwards        Pages: 101
    Summary Market Overview The global Methotrexate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.6% in the forecast period of 2020 to 2025 and will expected to reach USD 557.6 million by 2025, from USD 503.5 million in 2019. The Methotrexate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sale......
  • Global Paclitaxel Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 07-Jan-2020        Price: US 3480 Onwards        Pages: 106
    Summary Market Overview The global Paclitaxel market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.3% in the forecast period of 2020 to 2025 and will expected to reach USD 152 million by 2025, from USD 110.4 million in 2019. The Paclitaxel market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales anal......
  • Global Cytotoxic Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 03-Jan-2020        Price: US 3480 Onwards        Pages: 104
    Summary Market Overview The global Cytotoxic Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.0% in the forecast period of 2020 to 2025 and will expected to reach USD 15150 million by 2025, from USD 14580 million in 2019. The Cytotoxic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, ......
  • Global Hydroxycarbamide Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 122
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • Global Docetaxel Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 95
    Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein. The classification of Docetaxel includes 20 mg/ml, 40 mg/ml and 60 mg/ml. And the proportion of 20 mg/ml in 2017 is about 86% and the proportion is stable from 2013 to 2017. Do......
  • Global Cancer Treatment Drugs Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 130
    Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%. Cancer treatment drugs are widely used for blood cancer, breast......
  • Global Lentinan Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 03-Jan-2020        Price: US 3480 Onwards        Pages: 100
    Summary Market Overview The global Lentinan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 11 million by 2025, from USD 10 million in 2019. The Lentinan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, im......
  • Global Capecitabine Market Research Report 2020
    Published: 02-Jan-2020        Price: US 2900 Onwards        Pages: 93
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfer......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs